Bayouth J E, Maccy D J, Kasi L P, et al. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases[J]. J Nucl Med, 1994, 35(1): 63-69.
[2]
Luis Correa-González, Consuelo Arteaga de Murphy, Pablo Pichardo-Romero, et al.153Sm-EDTMP for Pain Relief of Bone Metastases from Prostate and Breast Cancer and Other Malignancies[J]. Archives of Medical Research, 2014, 45(4): 301-308.
[3]
Richard K, Valicenti E T, Charles I, et al. A Phase I Trial of Samarium-153-Lexidronam Complex for Treatment of Clinically Nonmetastatic High-Risk Prostate Cancer: First Report of a Completed Study[J]. International Journal of Radiation Oncology Biology Physics, 2011, 79(3): 732-737.
[4]
The United States Pharmacopeial Convention.USP36NF31[M]. USA: United States Pharmacopeia, 2012: 3536.
国家药典委员会. 中华人民共和国药典[ M ] . 二部. 北京:化学工业出版社,2005:附录181-182.
[7]
柳银黎，尹光荣，付博,等. 177Lu-EDTMP放化纯分析方法的建立[J]. 同位素，2010,23（3）:163-165.Liu Yin Li, Yin Guang rong, Fu Bo, et al. Establishment of analysis method for the radiochemical purity of 177Lu-EDTMP[J]. Journal of Isotopes, 2010, 23（3）: 163-165(in Chinese).
